复旦张江(01349)发布公告,本集团纳米技术平台抗肿瘤药物盐酸多柔比星脂质体注射...复旦张江(01349)发布公告,本集团纳米技术平台抗肿瘤药物盐酸多柔比星脂质体注射液(商标名:里葆多)(该药物)于2009年8月上市销售,为楷莱(Doxil/Caelyx)的国内首仿药,是国内外首个纳米药物的仿制药物。该药物是一种采用先进的隐形脂质体技术包封,具有被动靶向特性的多柔比星新剂型,它是蒽环类药物的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.